文献速递神经头颈MR

多参数MRI集成深度学习术前分类垂体神经内分泌肿瘤亚型

Multiparametric MRI-Based Ensemble Deep Learning for Preoperative Classification of Pituitary Neuroendocrine Tumor Subtypes.
PubMed 文献 · Acad Radiol · 2026-09-01

本研究为单中心回顾性研究,纳入593例经病理证实的垂体神经内分泌肿瘤患者,利用多参数MRI构建集成深度学习模型,按垂体转录因子进行术前亚型分类。结果显示,ROI+T2W+T1C+ADC组合测试集准确率为90.68%,macro-AUC为0.966。该模型有望减少对侵入性手术组织取样进行亚型分类的依赖。

要点

  • 多参数MRI组合(ROI+T2W+T1C+ADC)分类PitNET亚型测试集准确率最高。
  • 模型输出可作为术前预测垂体转录因子亚型的临床决策支持工具。
  • 阅片报告可提示PitNET亚型可能,辅助后续治疗决策。

核心结论

  • 基于多参数MRI的集成深度学习模型能够对垂体神经内分泌肿瘤进行稳健的术前无创亚型分类。

研究设计与样本

  • 单中心回顾性研究,纳入2010-2020年间593例经组织病理证实的垂体神经内分泌肿瘤患者。
  • 数据集按80:20划分,其中475例用于训练,118例用于测试。
  • 亚型构成包括112例T-box垂体转录因子、251例类固醇生成因子1(SF1)、157例垂体特异性阳性转录因子1及73例null亚型。

诊断标准与关键数值

  • 完整多参数配置(ROI+T2W+T1C+ADC)测试集准确率为90.68%(95% CI:84.7%-95.8%)。
  • 完整多参数配置(ROI+T2W+T1C+ADC)测试集macro-AUC为0.966(95% CI:0.933-0.992)。
  • 完整多参数配置(ROI+T2W+T1C+ADC)测试集macro-F1为0.871(95% CI:0.797-0.941)。
  • 完整多参数配置(ROI+T2W+T1C+ADC)测试集macro-sensitivity为0.886(95% CI:0.791-0.965)。
  • 完整多参数配置(ROI+T2W+T1C+ADC)测试集macro-specificity为0.986(95% CI:0.977-1.000)。

临床应用与阅片要点

  • 在具备多参数MRI资料时,可考虑将ROI+T2W+T1C+ADC作为深度学习模型输入用于术前PitNET亚型判断。
  • 该模型结果可作为常规阅片的辅助信息,但需结合临床及内分泌指标综合判断。

局限性

  • 本研究为单中心回顾性设计,结果的外推性可能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Pituitary neuroendocrine tumors (PitNETs) exhibit diverse biological behavior requiring accurate subtyping to guide treatment. Although the latest World Health Organization classification emphasizes pituitary transcription factors (PTFs) as essential subtyping markers, their assessment requires invasive surgical tissue sampling. This study aimed to develop a multiparametric magnetic resonance imaging (MRI)-based ensemble deep learning model for noninvasive preoperative PTF-based PitNET subtype classification.

MATERIALS AND METHODS: This single-institution retrospective study analyzed multiparametric MRI data from 593 patients with histopathologically confirmed PitNET (2010-2020), comprising 112 with T-box pituitary transcription factor, 251 with steroidogenic factor 1 (SF1), 157 with pituitary-specific positive transcription factor 1, and 73 null subtypes. The dataset was split 80:20, with 475 patients for training and 118 for testing. Multiple MRI input combinations: T2-weighted (T2W), contrast-enhanced T1-weighted (T1C), apparent diffusion coefficient (ADC), and tumor region of interest (ROI) were evaluated to identify the highest-performing configuration. Performance was assessed using accuracy, macro-area under the receiver operating characteristic curve (macro-AUC), macro-F1 score, macro-sensitivity, and macro-specificity, with bootstrap-based pairwise comparisons reported as 95% confidence intervals (CIs).

RESULTS: Among the evaluated MRI input combinations, the full multiparametric configuration (ROI+T2W+T1C+ADC) achieved the highest performance, with a test-set accuracy of 90.68% (95% CI: 84.7%-95.8%), macro-AUC of 0.966 (95% CI: 0.933-0.992), macro-F1 score of 0.871 (95% CI: 0.797-0.941), macrosensitivity of 0.886 (95% CI: 0.791-0.965), and macrospecificity of 0.986 (95% CI: 0.977-1.000).

CONCLUSION: The proposed multiparametric MRI-based ensemble deep learning model achieved robust noninvasive preoperative classification of PitNET subtypes, demonstrating its potential as a clinical decision-support tool to reduce reliance on invasive surgical tissue sampling for PTF-based subtyping.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ndimulunde, Lin, Lin, et al. Multiparametric MRI-Based Ensemble Deep Learning for Preoperative Classification of Pituitary Neuroendocrine Tumor Subtypes. Acad Radiol. 2026. PMID: 42680659. doi:10.1016/j.acra.2026.08.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。